Search





Search





Markets
/
Stocks
/
nasdaq-mcrb
/

Seres Therapeutics Inc

MCRB

Add to Watchlist

6.610USD

+0.150+2.32%

Close 06/18, 16:00（ET）Quotes delayed by 15 min

64.01MMarket Cap

LossP/E TTM

Seres Therapeutics Inc

6.610

+0.150+2.32%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Seres Therapeutics Inc's Company Valuation

Currency: USD Updated: 2026-06-18

Previous score

8.73

Change

0

The current valuation score of Seres Therapeutics Inc is 8.73, ranking 91 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.09, which is -1198937.38% below the recent high of 1035.80 and -5199.77% above the recent low of -4.58.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/S

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.

KeyAI

